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Landsteiner's  original  studies  (1)  on  hapten-antibody  interaction  were  ex- 
tended  by other workers  to  the production of antibodies  against  certain  bio- 
logically active, low molecular weight, organic compounds. Thus, Clutton et al. 
(2) were able to produce an antibody to thyroxine, by the injection of a thyrox- 
ine-protein  complex into rabbits,  and  this  antibody neutralized  the ability of 
thyroglobulin  to  raise  the  basal  metabolic  rate  of rats.  Similar  studies  with 
histamine  (3)  and  aspirin  (4)  have  demonstrated  that  antibodies  capable  of 
neutralizing the biological action of each of these compounds could be produced 
by  the  employment of  suitable  hapten-protein  complex antigen.  However,  a 
hapten-antibody reaction does not always result in neutralization of the biologi- 
cal  activity of the  hapten;  for example,  serologically demonstrable  antibody 
to adrenaline, fails to inhibit its pressor action (5). The present report describes 
the procedures used in the production and detection of antiangotensin  by the 
employment of benzoylangiotensin II-azo-BGG as the hapten-protein antigen. 
The preparation of this antigen has been described previously. 
Materials  amt  Mettwds 
ValineS-anglotensin II (aspartyl-/~-acid)-synthetic product obtained  through the courtesy 
of Dr. Schwyzer, Ciba Ltd., Switzerland. 
lsoleuvineS-Angiotensin 1 and//.--These  were natural products prepared  by the action 
of hog renin on horse serum angiotensinogen and were obtained through the courtesy of Dr. 
Skeggs and Dr. Kahn, Crile Veteran's  Administration  Hospital,  Cleveland. Purity over 98 
per cent for type II and 50 per cent for type I on the basis of dog units per miUigram N. 
Immunization Procedure.--Female rabbits  weighing between  3  to 3.5 kg.  were divided 
into four groups, with three of the groups consisting of two rabbits each and the fourth group 
of three rabbits.  Group 1 was a control group not subjected  to the immunization procedure, 
while groups 2, 3, and 4 were immunized with bovine gamma globulin  (BGG) alone, with 
benzoylangiotensin  II-azo-BGG or with angiotensin  II alone, respectively.  Immunizations 
were carried out according to the following procedure. The three antigen solutions were made 
up in buffered saline (9 parts of isotonic saline +  1 part of 0.1 ~s sodium phosphate buffer, 
pH 7.4) to which was added either  10 rag. BGG/mI., or 10 rag. benzoylangiotensin II-azo- 
BGG/ml. or 2.5 mg. angiotensin II/ml. All injections were given intraperitoneally.  For the 
first two injections of each series 1 ml. of each antigen  solution was thoroughly mixed with 
1 ml. of Freund's complete adjuvant to form a homogeneous colloidal suspension. The same 
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procedure was repeated a week later and from then on the injections consisted of 0.S ml. of 
antigen solutions without Freund's adjuvant given three times a week for a period of S weeks. 
Isolation of Rabbit ~/-Globulin.--At the end of the immunization  period all rabbits  were 
bled from the femoral artery and the plasma collected from each rabbit was fractionated  for 
~/-globulin according to the procedure described by Goldstein mad Anderson (6). The purity 
of these ~'-globulin fractions was checked by paper electrophoresis on a Spinco model R ap- 
paratus.  The outstanding  advantage of this  procedure  was  that  the antibody containing 
~,-globulln fraction prepared in this manner was free of serum angiotensinase activity which 
would have interfered with the assay procedure for anti-angiotensin. All "y-globulin  fractions 
were lyophilized mad stored under vacuum, as dry powders. 
Assay for  Antiangiotensln.--The  T-globulin  fraction  obtained  from the serum  of each 
rabbit was incubated with a known amount of angiotensin II, and, at the end of the incubation 
period, the reaction mixture was assayed for angiotensin activity by the dog assay procedure 
previously  described.  In addition,  the guinea pig ileum assay procedure,  as described  by 
Picarelli eta/. and Collins and Hamilton (7, 8), was used, especially when amounts of angio- 
tensin were too small to be assayed in the dog. For the calculation of unknown amounts of 
angiotensln n  from ileum responses, the method described by Burn (9) was used. 
Serological Procedures.--Antigen-antibody precipitin  reactions  were carried  out by the 
incubation of immune qt-globulin fraction with the appropriate antigen, for 1 hour, at 26-27°C., 
followed by 16 hours at 2-3°C. For incubation, all solutions were made up in buffered saline. 
The extent of precipitation was determined by measuring optical density (at 750 m#) of the 
reaction mixture in a Coleman Junior spectrophotometer  (8 x 8 x 100 mm. cuvettes). Because 
of certain obvious drawbacks in this approach for the study of precipitin reactions, these tests 
must be considered only qualitative.  In general, the serological demonstration  of antiangio- 
tensin  involved  (a)  a study of its precipitin  reaction with benzoylangiotensin ILazo-BGG 
and with BGG alone, (b) partial  inhibition of this precipitin reaction by angiotensin n, and 
(c)  precipitin  reaction  with  an angiotensin  II-proteln complex containing  a protein  other 
than  BGG. 
EXPERIME~fAL 
Table I  summarizes the results of experiments in which a  known amount of 
angiotensin II was incubated with the w-globulin fraction from each group of 
immunized  rabbits.  These  experiments  were  carried  out  under  conditions 
described below Table I. 
Adequacy  of  the  Goldstein-Anderson  procedure  for  the  isolation  of  an 
angiotensinase-free ~/-globulin from rabbit plasma  is  evident  from the  results 
shown in Table I  (Experiments 2, 3, and 5). We have further observed that the 
incubation of angiotensin II with normM rabbit ~/-globulin for as long as 2 to 
2~/~ hours at 37°C. does not result in any loss of angiotensin activity. Similarly, 
after  incubation  with q,-globulin  from  rabbits  immunized  with  BGG  alone 
(group  2),  the  total  initial  amount  of angiotensin  n  was recovered.  On  the 
other hand, ~/-globulin from group 3 rabbits (Table I, Experiment 4) inactivated 
a small but significant portion of added angiotensin n. The fact that in Experi- 
ment 5 no disappearance of angiotensin II activity was observed indicates that 
angiotensin n  is probably too small a  molecule to be antigenic by itself, since 
each rabbit  in  this  group was  immunized  with  an amount  of angiotensin  n 
equivalent to that used in the form of azo-BGG complex for the immunization 
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TABLE I 
Inaztivation of Anglotensin II  by Antiangiotcnsln 
No.  Experiment  Units of angiotensin  Inactivation 
II recovered  of angiotensin 
1. 
2. 
3. 
4. 
No T-globulin added 
T-globulin from untreated rabbits, group 1 
33-globulin  from rabbits given BGG, group 2 
33-globulin  from rabbits given angiotensin II-BGG- 
complex, group 3 
33-globulin  from rabbits given angiotensin II alone, 
group 4 
Group 3 3/-globulin  alone (no angiotensin II added) 
2.88 -4- 0.2 
2.76 -4- 0.2 
2.94 -4- 0.21 
1.90  -4- 0.18 
2.80  4-  0.21 
~er c¢~ 
0 
2 
0 
33~ 
Reaction mixture, 20 rag. 33-globulin  in 0.5 ml. buffered saline, 0.1 ml. (1.0 millimicromole 
or 2.8 dog units) angiotensin IL Incubated at 370C. for 75 minutes, at the end of the incu- 
bation period 2.2 nil. of buffered saline was added and the solution was then assayed in the 
dog. Each experiment in Table I was carried out in duplicate and each reaction mixture was 
assayed in two different dogs so that each figure  indicated in the above table represents an 
average of four determinations. 
* Standard deviation. 
This figure is significantly different from the "control" values (P <  0.01). 
TABLE II 
Specificity of Antiangiotensin 
Experiment 
No. 
1. 
2. 
3. 
4. 
5. 
Angiotensin analog 
Valiner-angiotensin II (aspartyl-/~ amide) 
VallneS-angiotemin  II (aspartyl-/~ acid) 
p-Aminobenzoylangiotensin II (aspartyl-fl 
amide) 
IsoleucineS-angiot  ensin II 
IsoleucineS-angiotensin  I 
Units of angiotensin 
recovered 
1.94 ..4- 0.18 
1.22  -4- 0.14 
0.8  -4- 0.1 
1.36 ±  0.15 
3.0  -4- 0.22 
Inactivation 
of 
angiotensin 
p~' ten| 
30.7 
56.7 
71.5 
51.5 
0 
Reaction mixture, 20 nag. of group 3 33-giobulin  in 0.5 nil. of buffered saline, 0.i ml. (2.8 
dog units) of the respective angiotensin analog. Remainder of the procedure same as that 
described below Table I. 
There is no significant difference between the values of Experiments 2 and 4. All other 
results  are significantly different from each other  (P value  <0.01). 
* Standard deviation. 
Specificity of Antiangiotensin.--Table  II shows a comparison of the effects of 
antiangiotensin on different analogs of  angiotensin. Experimental conditions 
used in this case are described below Table II. 
As indicated in Table II, antiangiotensin possesses greater activity in neu- 
tralizing the free acid form of angiotensin II than the amide form.  Since, in 432  IM~UNOLOGIC  PRODUCTION  OF  ANTIANGIOTENSIN.  II 
the preparation  of the azo-protein antigen,  the amide and  not the free acid 
form was used as the starting product, one would expect the opposite result. 
It is possible, however, that during one of the reactions employed in the coupling 
process the ~-amide group of aspartic acid was converted to the free acid form. 
The most likely reaction in this respect appears to be that involving diazotiza- 
tion  of p-aminobenzoylangiotensin  II  with  nitrous  acid  (HNO~),  since  this 
reagent is known to convert organic  amides into the corresponding free acids 
under  comparable  conditions  (10).  During  this  investigation,  no  direct  at- 
tempts were made to prove the occurrence of such a transformation. 
Table II also shows that, of all the different analogs,  p-aminobenzoylangio- 
tensin II is inactivated to the largest extent.  This may be attributed to the 
presence of the p-aminobenzoyl group, which brings this compound structurally 
closer  to the hapten  moiety of the benzoylangiotensin  II-azo-BGG complex 
antigen. 
A comparison of Experiments 2 and 4, in Table II, shows that the two forms 
of angiotensin  II,  (synthetic, valine  5 and  the natural,  isoleucine 5) are inacti- 
vated to about the same extent by antiangiotensin.  The substitution of valine 
for isoleucine,  the only difference  between these two octapeptides, does not 
affect the hapten-antibody interaction. On the other hand, antiangiotensin has 
no effect on angiotensin I  (Experiment 5, Table II) which differs from angio- 
tensin II in possessing  the additional dipeptide, histidyl-leucine, at the phenyl 
alanine  carboxyl end.  This  observation is  in  agreement  with  the  studies  of 
Landsteiner  (11)  on peptide haptens.  He demonstrated  that  the amino acid 
with the free carboxyl group at the carboxyl end of the peptide determines, to a 
large extent, the specificity of the respective antibody. Since the structure of 
angiotensin I  and angiotensin II differs markedly at the free carboxyl end, it 
follows from Landsteiner's  conclusion  that  antibody to angiotensin  II would 
show little or no affinity for angiotensin I. 
The  observation that  antiangiotensin  inactivates angiotensin II  (Table II, 
Experiment 4) but not angiotensin I  (Table II, Experiment 5),  further rules 
out the possibility that the antiangiotensin activity of group 3 "/-globulin,  may 
be due to a  contamination  of this fraction with serum angiotensinase,  since 
the latter inactivates both forms of angiotensin.  Figure 1 represents an experi- 
ment in which normal rabbit serum was incubated with known, equal amounts 
of  angiotensin  II  (aspartyl-/~-amide),  angiotensin  II  (aspartyl-/~-acid)  and 
angiotensin I and the amount of angiotensin left in each incubate at different 
time intervals  was determined.  The  conditions used for this  experiment  are 
described below Fig. 1. 
Serological Studies.--The  group  3  rabbit  "t-globulin  solution,  containing 
antiangiotensin,  readily  showed  a  precipitin  reaction  upon  addition  of 
benzoylangiotensin  II-azo-BGG.  Precipitation  was  also  observed with BGG 
alone,  but larger amounts of protein were needed in this case to bring about SHARAD  D.  DEODHAR  433 
maximum precipitation.  This is illustrated in Fig.  2, in which  the amount of 
precipitate  formed,  as  indicated  by  the  optical  density  of  the  solution,  is 
plotted  against  the  corresponding  amount  of antigen  protein  added  in  each 
case. 
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FIG.  1.  Inactivation  of angiotensin derivatives by serum angiotensinase 
[] .....  •,  angiotensin I;  O  O, angiotensin II (acid); •  .....  O,  angiotensin LI 
(amide). 
(Reaction mixture--2  ml. normal rabbit serum; 0.4 ml. (12 dog units) of the respective 
angiotensin solution; incubated at 37°C. 
At 0, 30, 60, and 90 minutes, 0.6 nil. of the reaction mixture was withdrawn, and to this 
was added 0.04 ml. of 1 N HCI. The acidified solution was heated in boiling water for 5 minutes 
to terminate angiotensinase activity and to coagulate and precipitate serum proteins. 0.04 ml. 
of 1 ~ NaOH and 2.7 ml. of buffered saline were then added and the suspension was centri- 
fuged. Supernatant obtained from this ceatfifugation was assayed for angiotensin in the dog). 
Fig. 2 indicates that the introduction of p-aminobenzoylangiotensin II resi- 
dues into BGG changes the antigenic nature of the latter, so that the antibody 
produced  in  response  to  benzoylangiotensin-azo-BGG  shows  a  distinctly 
higher a~fity for the BGG-azo complex than for BGG alone. A similar example 
of this phenomenon may be found in the studies of Heidelberger et al.  (12) on 
the  quantitative  precipitin  reactions  of  anti-azo-egg  albumin  with  azo-egg 
albumin and with native egg albumin. The type of curve illustrated  in Fig. 2 
is often seen for many of the  so called cross-reactions, in which  the antigen 
and antibody do not fit very well and large amounts of antigen are needed for 
maximal precipitation. 
The precipitate formed after the addition of BGG to group 3 y-globulin did 434  IMMUNOLOGIC  PRODUCTION  OF  ANTIANGIOTENSIN.  IX 
not  remove  antiangiotensin,  and,  after  centrifugafion,  the  supernatant  was 
found to contain the full antiangiotensin activity of the original solution. 
It was not possible to carry out a  similar experiment with the supematant 
obtained from the precipifin reaction of group 3 ~/-globulin  with benzoylangio- 
tensin  II-azo-BGG,  since  this  latter  preparation  itself  was  found  to  have 
considerable angiotensin II (pressor) activity (13). 
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FIo.2. Precipitin reactions of antiangiotensin. 
O, angiotensin ILazo-BGG; O, BGG alone. 
(To 0.25 ml. of group 3 ')'-globulin (20 mg./ml.) containing antiangiotensin were added 
increasing amounts of each antigen, dissolved in buffered saline. Final volume 1 ml. in each 
tube; incubated at 26°C. for 1 hour and at 2-3°C. for 16 hours. The resulting suspension  was 
diluted to 2 ml. with buffered saline and its optical density determined. Controls, q,-globulin 
solution, in buffered  saline, and each antigen alone, in buffered  saline.) 
Inhibition of Precipitin Reaction.--Ability  of a  hapten  to  inhibit  the pre- 
cipitin  reaction  between  the  hapten-protein  complex  and  its  antiserum  is 
usually considered as evidence for the existence of antibodies to the hapten. 
In the case of antiangiotensin, the phenomenon of hapten inhibition was demon- 
strated in the following manner. A given amount of group 3 3,-globulin (anti- 
angiotensin)  was  incubated  with increasing  amounts  of angiotensin  II  and, 
following this incubation, the precipitin reaction was carried out in the usual 
manner by the addition of the same amount of benzoylangiotensin II-azo-BGG SHARAD V.  DEOD~AR  435 
to all the reaction mixtures.  Fig.  3 represents the results obtained from such 
an experiment. 
It is apparent from Fig. 3 that angiotensin II shows a  significant inhibition 
of  the  precipitin  reaction  between  antiangiotensin  and  its  corresponding 
antigen, whereas it has practically no effect on the reaction between anti-BGG 
and BGG. The phenomenon of hapten inhibition  is usually explained by the 
0.4 
o 
as 
z  O.2 
r~ 
< 
U 
r-  0.1 
n 
0 
I  I  u  I  i  I  I  I 
® 
l  I  ~  I  ,  I  i  I 
0  I0  20  30  40 
ANGIOTENSIN  II  --  rag. 
FIG. 3.  Inhibition of the precipitin reaction by angiotensin II. 
(~), BGG; (~), angiotensin II-azo-BGG. 
To 0.25 ml. of group 3 "y-globulin (20 mg./ml.) were added 0, 10, 20, and 40 mg. of angio- 
tensin II; total volume 0.5 ml. 
Incubated at 37°C. for 1 hour. To each incubate was added 0.4 mg. of benzoylangiotensin 
II-aso-BGG in 0.5 ml. solution and the precipitin reaction was studied in the manner pre- 
viously described. An identical experiment was set up to study the effect of angiotensin II 
on the precipitin reaction between group 2 'y-globulin (from rabbits immunized with BGG 
alone) and BGG. 
hypothesis that the hapten molecules block the active sites on the corresponding 
antibody, thereby preventing later combination with the homologous antigen. 
The possibility that larger amounts of angiotensin II might produce a greater 
degree of inhibition  could not  be tested,  because the amount  of angiotensin 
II  available  was  limited.  For  the  same  reason,  inhibition  by  angiotensin 
II (free acid form) was not tested at all. In the case of several synthetic pep- 
tides  that  were studied  by Landsteiner  (11),  the precipitin reaction between 
benzoylpeptide-azo-protein  antigen  and  the  corresponding  antiserum  was 
inhibited by the p-aminobenzoyl derivative, but not by the free peptide itself. 436  IMMUNOLOGIC  PRODUCTION  OF  ANTIANGIOTENSIN.  H 
On the other hand, both histamine and p-aminobenzoylhistamine could effec- 
tively inhibit  the  precipitin reaction between histamine-azo  protein  and  its 
antiserum (3). It was pointed out previously that p-aminobenzoylangiotensin 
II was  the angiotensin derivative most effectively antagonized by antiangio- 
tensin (Table II, Experiment 3); one might expect this derivative to be highly 
effective in inhibiting the precipitin reaction as well. Unfortunately, the solubil- 
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Fro.  4. Precipitin reaction of antiangiotensin with a  different angioteusin II-protein 
complex. 
(~), angiotensin H-azo-cat serum +  "y-globulin  3; (~), eat serum +  3"-globulin  3; (~), cat 
serum +  3'-globulin 2; (~), angiotensin II-axo-cat serum +  3"-globulin  2. 
10 rag. of dialyzed, lyophilized cat serum was coupled with 2.5 nag. of p-aminobenzoyl- 
angiotensin II according to the procedure described previously. To 0.25 ml. of group 3 or 
group 2 3,-globulin (20 mg./ml.) were added increasing amounts of cat serum protein and 
ben~ylangioteusln II-azo-cat serum protein. Final volume 1 ml. Preclpitin reactions were 
studied, as described previously,  with appropriate controls. 
ity of p-aminobenzoylangiotensin II at or near the pH of neutrality is too low 
to permit such a study. 
Precipitin Reaction of Antiangiotensin  with a Different Angiotensin H-Protein 
Complex.--F~ther  evidence for  the  presence of antiangiotensiu  in group  3 
"y-globulin was derived from the observation that a precipitin reaction could be 
demonstrated not only with its corresponding antigen, but also with p-amino- 
benzoylangiotensin II coupled to cat serum protein. Group 3 "/-globulin cross- 
reacts to a certain extent with cat serum alone; however, the degree of precipi- 
tation is increased significantly upon the addition of benzoylangiotensin-azo- 
cat serum protein. This experiment is illustrated in Fig. 4. SHARAD  D.  DEODHAR  437 
This type of evidence has been used to demonstrate the presence of antibody 
to a hapten. During their studies on the production and detection of antibody 
to histamine, Fell and collaborators (3) observed that the antiserum obtained 
in response to administration of histamine-azo-globulin  (horse)  to rabbits, could 
enter into a precipitin reaction with histamine coupled to a variety of proteins, 
including  rabbit  serum,  casein,  egg albumin,  and  others.  Many examples of 
this phenomenon may be found in the classical studies of Landsteiner. 
DISCUSSION 
By the use of many of the criteria estabished for the detection of antibody 
to a hapten, it was possible to show that the parenteral administration of the 
angiotensin-BGG  complex,  (benzoylangiotensin  II-azo-BGG)  to  rabbits, 
results in the production of an antiserum containing antiangiotensin  activity. 
The ability of this antiserum to neutralize (in vitro)  the biological action (pres- 
sor activity, and smooth muscle contraction) of angiotensin II, and the speci- 
ficity of this  neutralization,  the  partial  inhibition  of the precipitin  reaction 
between the  antiserum  and  the angiotensin  complex by angiotensin  II,  and 
the  precipitin  reaction  of  the  antiserum  with  another  angiotensin  protein 
complex (benzoylangiotensin II-azo-cat serum) are among the most pertinent 
findings  that  establish  conclusively the  formation  of  antiangiotensin.  Since 
our interests at present are directed mainly towards the neutralization  of the 
pressor  activity of angiotensin  by antiangiotensin,  and  also  because of  the 
limited amount of angiotensin II available to us, the serological tests described 
in this report were used only for a qualitative demonstration of antiangiotensin. 
In comparing the two antigen-antibody systems investigated so far in rela- 
tion  to  the  humoral  mechanism  of  renal  hypertension,  namely  the  renin- 
antirenin  (14)  and  angiotensin  II-antiangiotensin  systems,  the  rapidity  of 
interaction and the high titers of antibody as seen in the former case become 
worthy of consideration. Thus, in the rabbit, antirenin titers of up to 10 units 
per ml.  serum,  (and  even higher  in  other animals)  were produced after  the 
injection  of hog renin,  whereas the highest  titer  of antiangiotensin  was 0.8 
units per ml. serum (i.e.  10 mg. of "),-globulin). Also the inhibition of renin by 
antirenin,  in vitro, occurs instantaneously, while an incubation period of about 
75 minutes is necessary to produce the maximal  effect of antiangiotensin.  It 
remains to be seen how these factors influence  the activity of antiangiotensin 
in vivo.  Studies on the effect of this immunization procedure with benzoylangio- 
tensin II-azo-BGG on the hypertensive course of renal hypertensive dogs and 
rabbits are currently in progress in our laboratories. 
SUMMARY 
The parenteral administration of benzoylangiotensin II-azo-BGG to rabbits 
produced an antiserum with antiangiotensin activity. 438  IMMUNOLOGIC  PRODUCTION  OF  ANTIANGIOTENSIN.  II 
Antiangiotensin inhibited the biological action of p-aminobenzoylangiotensin 
II,  valine~-angiotensin  II  (free  acid  form),  isoleucine~-angiotensin  II  and 
valineS-angiotensin  II  (amide form),  but  it  was  totally  inert  towards  angi- 
otensin I. 
Antiangiotensin activity was distinguished from that of serum angiotensinase 
by the  following observations:  (a)  an  angiotensinase-free  h'-globulin  fraction 
contained antiangiotensin,  (b) angiotensinase inactivated angiotensin  II (both 
the amide and free acid forms) and angiotensin I in contrast to the remarkable 
specificity for angiotensin II exhibited by antiangiotensin. 
Serological demonstration  of antiangiotensin  included:  (a)  a  comparison of 
its precipitin  reaction  with  the  angiotensin  BGG complex with  the  reaction 
with BGG alone, (b)  the partial  inhibition  of the precipitin  reaction with the 
angiotensin  BGG complex by angiotensin  II,  (c)  a  precipitin  reaction  with a 
different angiotensin II protein complex (cat serum). 
Angiotensin  II  administered  parenterally  as  the  free polypeptide  was not 
antigenic. 
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